Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


04.03.2019

4 Clin Infect Dis
1 Dig Dis Sci
2 Eur J Gastroenterol Hepatol
1 Gastroenterology
1 Hepatology
2 J Clin Microbiol
4 J Hepatol
3 J Med Virol
11 J Viral Hepat
2 Lancet Gastroenterol Hepatol
1 MMWR Morb Mortal Wkly Rep
3 PLoS One
1 PLoS Pathog
1 Virology
1 Virology (Auckl)


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Clin Infect Dis

  1. CHEN SH, Lai HC, Chiang IP, Su WP, et al
    Performance of Acoustic Radiation Force Impulse Elastography for Staging Liver Fibrosis in Patients with Chronic Hepatitis C after Viral Eradication.
    Clin Infect Dis. 2019 Feb 28. pii: 5366592. doi: 10.1093.
    PubMed     Text format     Abstract available

  2. RAMIERE C, Charre C, Miailhes P, Bailly F, et al
    Patterns of HCV transmission in HIV-infected and HIV-negative men having sex with men.
    Clin Infect Dis. 2019 Feb 27. pii: 5365873. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. GEDDES L, Iversen J, Wand H, Esmaeili A, et al
    Sex discrepancies in the protective effect of opioid agonist therapy on incident hepatitis C infection.
    Clin Infect Dis. 2019 Feb 28. pii: 5366653. doi: 10.1093.
    PubMed     Text format     Abstract available

  4. BOETTIGER DC, Salazar-Vizcaya L, Dore GJ, Gray RT, et al
    Can Australia reach the World Health Organization Hepatitis C elimination goal by 2025 among HIV-positive gay and bisexual men?
    Clin Infect Dis. 2019 Feb 28. pii: 5366676. doi: 10.1093.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  5. JIAN ZW, Wu XW, Chen ZX, Wang JC, et al
    Effect of Nucleos(t)ide Analogs on Patients with Intermediate and Advanced Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Feb 28. pii: 10.1007/s10620-019-05543.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  6. LIAN MJ, Zhang JQ, Chen SD, Zhang DD, et al
    Diagnostic accuracy of gamma-glutamyl transpeptidase-to-platelet ratio for predicting hepatitis B-related fibrosis: a meta-analysis.
    Eur J Gastroenterol Hepatol. 2019 Feb 21. doi: 10.1097/MEG.0000000000001381.
    PubMed     Text format     Abstract available

  7. SANDMANN L, Dorge P, Wranke A, Vermehren J, et al
    Treatment strategies for patients with decompensated liver cirrhosis due to hepatitis C virus infection eligible for liver transplantation: real-life data from five German transplant centers.
    Eur J Gastroenterol Hepatol. 2019 Feb 21. doi: 10.1097/MEG.0000000000001386.
    PubMed     Text format     Abstract available


    Gastroenterology

  8. TORRES HA, Pundhir P, Mallet V
    Hepatitis C virus infection in patients with cancer: impact on clinical trial enrollment, selection of therapy, and prognosis.
    Gastroenterology. 2019 Feb 21. pii: S0016-5085(19)30435.
    PubMed     Text format    


    Hepatology

  9. ZHOU C, Wang W, Mu Y
    Allogeneic Mesenchymal Stem Cells Therapy for the Treatment of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.
    Hepatology. 2018;68:1660-1661.
    PubMed     Text format    


    J Clin Microbiol

  10. HERMELIN D, Demske M, Chamberland RR, Sotelo-Avila C, et al
    Closing the Brief Case: Incidental Finding of Cystic Echinococcosis during Evaluation for Hepatitis.
    J Clin Microbiol. 2019;57.
    PubMed     Text format    

  11. HERMELIN D, Demske M, Chamberland RR, Sotelo-Avila C, et al
    The Brief Case: Incidental Finding of Cystic Echinococcosis during Evaluation for Hepatitis.
    J Clin Microbiol. 2019;57.
    PubMed     Text format    


    J Hepatol

  12. MORGAN FREIMAN J, Wang J, Easterbrook PJ, Robert Horsburgh C, et al
    Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: analysis of a global dataset.
    J Hepatol. 2019 Feb 20. pii: S0168-8278(19)30125.
    PubMed     Text format     Abstract available

  13. SAHLI R, Fraga M, Semela D, Moradpour D, et al
    Rabbit HEV in immunosuppressed patients with hepatitis E acquired in Switzerland.
    J Hepatol. 2019 Feb 22. pii: S0168-8278(19)30068.
    PubMed     Text format    

  14. DEVARBHAVI H, Asrani SK, Kamath PS
    Reply to: "Alcohol-associated liver disease, not hepatitis B, is the major cause of cirrhosis in Asia".
    J Hepatol. 2019 Feb 19. pii: S0168-8278(19)30066.
    PubMed     Text format    

  15. MERAT SJ, Bru C, van de Berg D, Molenkamp R, et al
    Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance.
    J Hepatol. 2019 Feb 20. pii: S0168-8278(19)30128.
    PubMed     Text format     Abstract available


    J Med Virol

  16. IIDA-UENO A, Enomoto M, Kozuka R, Tamori A, et al
    Switching to tenofovir disoproxil fumarate versus continuing treatment in chronic hepatitis B patients who maintain long-term virological response to entecavir therapy: a randomized trial.
    J Med Virol. 2019 Feb 28. doi: 10.1002/jmv.25442.
    PubMed     Text format     Abstract available

  17. SONG C, Shan Z, Kang F, Li W, et al
    A 3-year-long investigation of the authenticity of the return results of hepatitis B virus qualitative testing in external quality assessment in East China.
    J Med Virol. 2019 Feb 13. doi: 10.1002/jmv.25431.
    PubMed     Text format     Abstract available

  18. HSU CW, Yeh C, Yeh CT
    Maintaining complete virological suppression by reduced doses of nucleos(t)ide analogue in chronic hepatitis B patients.
    J Med Virol. 2019 Feb 28. doi: 10.1002/jmv.25443.
    PubMed     Text format     Abstract available


    J Viral Hepat

  19. LATHAM NH, Pedrana A, Doyle JS, Howell J, et al
    Community-based, point-of-care hepatitis C testing: perspectives and preferences of people who inject drugs.
    J Viral Hepat. 2019 Feb 23. doi: 10.1111/jvh.13087.
    PubMed     Text format     Abstract available

  20. LIM SG, Agcaoili J, De Souza NNA, Chan E, et al
    Therapeutic Vaccination for Chronic Hepatitis B: A Systematic Review and Meta-analysis.
    J Viral Hepat. 2019 Feb 23. doi: 10.1111/jvh.13085.
    PubMed     Text format     Abstract available

  21. DORE GJ
    HCV reinfection as a positive indication of high-risk population treatment access.
    J Viral Hepat. 2019 Feb 25. doi: 10.1111/jvh.13092.
    PubMed     Text format     Abstract available

  22. TURKOVA A, Volynets GV, Crichton S, Skvortsova TA, et al
    Advanced liver disease in Russian children and adolescents with chronic hepatitis C.
    J Viral Hepat. 2019 Feb 25. doi: 10.1111/jvh.13093.
    PubMed     Text format     Abstract available

  23. MARTINEZ MG, Testoni B, Zoulim F
    Biological basis for functional cure of chronic hepatitis B.
    J Viral Hepat. 2019 Feb 25. doi: 10.1111/jvh.13090.
    PubMed     Text format     Abstract available

  24. PLATT L, Stengel CM, Nkurunziza M, Muhangi D, et al
    Assessing risk of HIV and hepatitis C among people who inject drugs in East Africa: findings from a rapid assessment.
    J Viral Hepat. 2019 Feb 27. doi: 10.1111/jvh.13088.
    PubMed     Text format     Abstract available

  25. WILSON EC, Turner C, Lin J, McFarland W, et al
    Hepatitis C seroprevalence and engagement in related care and treatment among transwomen.
    J Viral Hepat. 2019 Feb 27. doi: 10.1111/jvh.13089.
    PubMed     Text format     Abstract available

  26. KARIMZADEH H, Usman Z, Frishman D, Roggendorf M, et al
    Genetic diversity of hepatitis D virus genotype 1 in Europe allows classification into subtypes.
    J Viral Hepat. 2019 Feb 23. doi: 10.1111/jvh.13086.
    PubMed     Text format     Abstract available

  27. LOMBARDI A, Rossotti R, Moioli MC, Merli M, et al
    The impact of HIV infection and MSM status on hepatitis A infection: the experience of two tertiary centres in Northern Italy during the 2017 outbreak and in the 2009-2016 period.
    J Viral Hepat. 2019 Feb 22. doi: 10.1111/jvh.13082.
    PubMed     Text format     Abstract available

  28. VAN HEES S, Chi H, Hansen B, Bourgeois S, et al
    Sustained off-treatment viral control is associated with high Hepatitis B Surface Antigen seroclearance rates in Caucasian patients with Nucleos(t)ide Analogue induced HBeAg seroconversion.
    J Viral Hepat. 2019 Feb 23. doi: 10.1111/jvh.13084.
    PubMed     Text format     Abstract available

  29. VANOPDORP JR, Ferrentino N, Strader DB, Lidofsky SD, et al
    Utility of laboratory monitoring during hepatitis C treatment with ribavirin-free direct acting antiviral regimens.
    J Viral Hepat. 2019 Feb 23. doi: 10.1111/jvh.13083.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  30. WONG GL, Wong VW, Chan HL
    Towards finite oral antiviral treatment for chronic hepatitis B.
    Lancet Gastroenterol Hepatol. 2019 Feb 19. pii: S2468-1253(19)30045.
    PubMed     Text format    

  31. BUTI M, Wong DK, Gane E, Flisiak R, et al
    Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials.
    Lancet Gastroenterol Hepatol. 2019 Feb 19. pii: S2468-1253(19)30015.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  32. WOODRING J, Pastore R, Brink A, Ishikawa N, et al
    Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Western Pacific Region, 2005-2017.
    MMWR Morb Mortal Wkly Rep. 2019;68:195-200.
    PubMed     Text format     Abstract available


    PLoS One

  33. VILLAR LM, Geloneze B, Vasques ACJ, Pires MLE, et al
    Prevalence of hepatitis B and hepatitis C among diabetes mellitus type 2 individuals.
    PLoS One. 2019;14:e0211193.
    PubMed     Text format     Abstract available

  34. JANG Y, Ahn SH, Lee K, Lee J, et al
    Psychometric evaluation of the Korean version of the Hepatitis B Quality of Life Questionnaire.
    PLoS One. 2019;14:e0213001.
    PubMed     Text format     Abstract available

  35. GRANADOS-GARCIA V, Flores YN, Diaz-Trejo LI, Mendez-Sanchez L, et al
    Estimating the prevalence of hepatitis C among intravenous drug users in upper middle income countries: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0212558.
    PubMed     Text format     Abstract available


    PLoS Pathog

  36. NEGASH AA, Olson RM, Griffin S, Gale M Jr, et al
    Modulation of calcium signaling pathway by hepatitis C virus core protein stimulates NLRP3 inflammasome activation.
    PLoS Pathog. 2019;15:e1007593.
    PubMed     Text format     Abstract available


    Virology

  37. JALAL PJ, King BJ, Saeed A, Adedeji Y, et al
    Elevated serum activity of MBL and ficolin-2 as biomarkers for progression to hepatocellular carcinoma in chronic HCV infection.
    Virology. 2019;530:99-106.
    PubMed     Text format     Abstract available


    Virology (Auckl)

  38. QUAYE O, Amuzu BG, Adadey SM, Tagoe EA, et al
    Effect of Hepatitis B Virus (HBV) Infection on Lipid Profile in Ghanaian Patients.
    Virology (Auckl). 2019;10:1178122X19827606.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: